Table A2.
Correlations between UL, UL (w/o trauma), UT and ULT and SES, sex, ethnicity, genotype, SLC6A4_1pc, methylation and SES*SLC6A4 methylation interaction
| U score | SES | Male versus Female | Ethnic. | Geno. | SLC6A4_1pc meth. | SES*SLC6A4_1pc meth. | |
|---|---|---|---|---|---|---|---|
| UL (n = 100) | |||||||
| UL | 1.000 | 0.146 | 0.006 | 0.032 | 0.043 | −0.367a | −0.257a |
| SES | 0.146 | 1.000 | 0.142 | 0.109 | −0.191a | −0.142 | −0.239a |
| Male versus Female | 0.006 | 0.142 | 1.000 | −0.025 | −0.090 | −0.326a | −0.053 |
| Ethnicity | 0.032 | 0.109 | −0.025 | 1.000 | −0.441a | −0.283a | 0.101 |
| Genotype | 0.043 | −0.191a | −0.090 | −0.441a | 1.000 | 0.146 | 0.012 |
| SLC6A4_1pc meth. | −0.367a | −0.142 | −0.326a | −0.283a | 0.146 | 1.000 | 0.110 |
| SES*SLC6A4_1pc meth. | −0.257a | −0.239a | −0.053 | 0.101 | 0.012 | 0.110 | 1.000 |
| UL (w/o trauma) (n = 69) | |||||||
| UL (UL w/o UT) | 1.000 | 0.219a | 0.007 | 0.154 | −0.064 | −0.361a | −0.252a |
| SES | 0.219a | 1.000 | 0.174 | 0.081 | −0.174 | −0.274a | −0.660a |
| Male versus Female | 0.007 | 0.174 | 1.000 | 0.007 | −0.173 | −0.375a | 0.042 |
| Ethnicity | 0.154 | 0.081 | 0.007 | 1.000 | −0.462a | −0.316a | −0.066 |
| Genotype | −0.064 | −0.174 | −0.173 | −0.462a | 1.000 | 0.202a | 0.088 |
| SLC6A4_1pc meth. | −0.361a | −0.274a | −0.375a | −0.316a | 0.202a | 1.000 | −0.091 |
| SES*SLC6A4_1pc meth. | −0.252a | −0.660a | 0.042 | −0.066 | 0.088 | −0.091 | 1.000 |
| UT (n = 100) | |||||||
| UT (n = 100) | 1.000 | 0.361a | −0.147 | 0.110 | −0.251a | 0.206a | 0.207a |
| SES | 0.361a | 1.000 | 0.142 | 0.109 | −0.191a | −0.142 | −0.239a |
| Male versus Female | −0.147 | 0.142 | 1.000 | −0.025 | −0.090 | −0.326a | −0.053 |
| Ethnicity | 0.110 | 0.109 | −0.025 | 1.000 | −0.441a | −0.283a | −0.049 |
| Genotype | −0.251a | −0.191a | −0.090 | −0.441a | 1.000 | 0.146 | 0.012 |
| SLC6A4_1pc meth. | 0.206a | −0.142 | −0.326a | −0.283a | 0.146 | 1.000 | 0.110 |
| SES*SLC6A4_1pc meth. | 0.207a | −0.239a | −0.053 | −0.049 | 0.012 | 0.110 | 1.000 |
| UL/trauma (n = 100) | |||||||
| UL/trauma (UTL) | 1.000 | 0.262a | −0.062 | 0.048 | −0.048 | −0.204a | −0.088 |
| SES | 0.262a | 1.000 | 0.142 | 0.109 | −0.191a | −0.142 | −0.239a |
| Male versus Female | −0.062 | 0.142 | 1.000 | −0.025 | −0.090 | −0.326a | −0.053 |
| Ethnicity | 0.048 | 0.109 | −0.025 | 1.000 | −0.441a | −0.283a | −0.049 |
| Genotype | −0.048 | −0.191a | −0.090 | −0.441a | 1.000 | 0.146 | 0.012 |
| SLC6A4_1pc meth. | −0.204a | −0.142 | −0.326a | −0.283a | 0.146 | 1.000 | 0.110 |
| SES*SLC6A4_1pc meth. | −0.088 | −0.239a | −0.053 | −0.049 | 0.012 | 0.110 | 1.000 |
SES, socioeconomic status; UL, unresolved loss; ULT, unresolved loss and trauma; UT, unresolved trauma.
a
P < 0.05.